Egypt's pharmaceutical industry is experiencing significant growth, driven by a rising population, increasing healthcare expenditure, and government initiatives to promote local manufacturing. The demand for pharmaceutical intermediates and fine chemicals is therefore increasing, presenting opportunities for both local and international suppliers. The geographical location and relatively stable political environment are also attracting investment in this sector.
However, the industry faces challenges, including reliance on imported raw materials, limited research and development capabilities, and competition from lower-cost producers. Water scarcity is a critical issue, increasing the need for industrial water treatment chemicals. Addressing these challenges is crucial for sustainable growth.
The regulatory framework is evolving, with the Egyptian Drug Authority (EDA) working to align with international standards. This progress is encouraging for foreign investment and technology transfer.
